They are the kind of results that a drug company prays for: a 54 percent reduction in heart attacks for patients taking AstraZeneca P.L.C.'s Crestor compared with a placebo. A 44 percent reduction in heart problems, such as stroke.
Copyright PHILY - Philly.com
